Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05096416 · ClinicalTrials.gov registry record · NA
Three-dimensional (3D) Printed Hemodialysis Vascular Model
A NA study, sponsored by Brigham and Women's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05096416 is a NA study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT05096416, a NA study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Infiltration of a surgically-placed hemodialysis vascular access (HVA) is recognized as a major contributor to the high hospital re-admission rate in dialysis-dependent patients. Three dimensional modeling has been demonstrated as a critical tool for procedurists in preparation for surgical interventions but no such modeling is yet available for dialysis specialists to avoid the common complication of HVA infiltration. Contrast enhanced magnetic resonance angiography (MRA) can be used to generate a three dimensional image data that could render a three dimensional resin-based model of a vascular access.
Interventions
- DEVICE The three-dimensional (3D) printed hemodialysis vascular model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05096416
The ClinicalTrials.gov registry entry for NCT05096416 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The three-dimensional (3D) printed hemodialysis vascular model is the first listed.
NCT05096416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05096416 about?
NCT05096416 is a clinical study titled "Three-dimensional (3D) Printed Hemodialysis Vascular Model". Infiltration of a surgically-placed hemodialysis vascular access (HVA) is recognized as a major contributor to the high hospital re-admission rate in dialysis-dependent patients. Three dimensional modeling has been demonstrated as a critical tool for procedurists in preparation for surgical interven...
What is the current status of trial NCT05096416?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-01-01. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT05096416?
The interventions under investigation include: The three-dimensional (3D) printed hemodialysis vascular model (DEVICE).
Who is sponsoring clinical trial NCT05096416?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.